Discover Syntara’s latest Phase 2a trial results for amsulostat in myelofibrosis, showing breakthrough symptom relief and strong pipeline updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback